Any paper plant willing to attempt to use a titanium dioxide substitute product on a trial basis will have to shut down completely and use tons of the substitute material to produce tons of paper over several days of normal manufacturing. Solv-Ex possesses no production capacity to produce this amount, or any amount, of any titanium dioxide substitute. A paper plant operator would require a producer of an alleged titanium dioxide substitute to have a fully functioning commercial plant with a well proven capacity to deliver required quantities and qualities at stable prices. Neither Solv-Ex nor Raisio possess, or even have any plans to attempt to create, any of these basic requirements. Short selling involves a risk not associated with the purchase of stock including, but not only limited to, unlimited loss and stock borrowing risks.
Additional information is available upon request.